Tamoxifen Citrate | non-steroidal agent |
Exemestane | an aromatase inhibitor |
Anastrozole | used when using substantial amounts of aromatizing steroids |
Stanozolol | Cutting Cycles |
Toremifene Citrate | non-steroidal selective Estrogen receptor modulator |
Drostanolone Propionate | Anabolic Steroid |
Methenolone Enanthate | the protein hormone assimilation strong activity of the liver |
17-methyltestosterone | androgen and Albumen Assimilation steroids |
Fluoxymesterone | can be used as pharmaceutical material |
Formestan | Used as an aromatic enzyme inhibitor |
Breast Cancer | 10 to 20 mg orally twice daily |
For metastatic breast cancer | 20 to 40 mg given in divided |
Women with Ductal Carcinoma | 20 mg daily for 5 years |
Reduce the incidence of breast cancer | 20mg daily for 5 years |
Node-positive breast cancer,axillary dissection | 10 mg orally 2 to 3 times daily for 5 years. |
Girls age 2 to 10 years with McCune-Albright Syndrome | 20 mg daily for one year |
Tamoxifen citrate | Approved to prevent: Breast cancer in women who are at high risk for the disease. |
Breast cancer in women and men | |
being studied in the treatment of other types of cancer. |